Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Clinical trial NCT07000253 · RECRUITING

Trial details

NCT number: NCT07000253
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer Gastric (Stomach) Cancer Gastric Adenocarcinoma Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Esophageal Carcinoma Gastric (Cardia, Body) Cancer

Start date: 2026-04-29
Primary completion: 2031-06-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.